Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
212.50    0.00 (0.00%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £145.08m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Directorate Change

10 Feb 2025 07:00

RNS Number : 4923W
Helios Underwriting Plc
10 February 2025
Β 

10 February 2025

Helios Underwriting PLC

Β 

("Helios" or the Company)

Β 

Directorate Change

​

Helios Underwriting, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, announces that Michael Wade, Executive Chairman, has decided to step down from his role at the end of February to continue developing his non-executive portfolio.

John Chambers, currently a Non-Executive Director will become Interim Executive Chairman.

Since Michael joined Helios as Non-Executive Chairman in June 2023, he has successfully guided the Company through a period of change and strong performance.

Most recently as Executive Chairman, he oversaw the Group's portfolio restructuring, materially reducing the Company's underwriting risk, gearing and overall cost base for 2025. These strategic priorities will remain unchanged under John Chambers.

John Chambers joined the Board of Helios as an Independent Non-Executive Director in July 2024 and has extensive underwriting and executive experience across the London Market. He was latterly Director of Underwriting at AEGIS London where he helped build the business from a fledgling syndicate into one of the largest and most profitable in the London Market.

He brings considerable experience across all aspects of running a regulated insurer, from business planning through underwriting management to risk management, as well as financial and regulatory reporting.

John Chambers, Interim Executive Chairman commented:

"On behalf of the board, I thank Michael for his leadership and he leaves with our best wishes. He has played a key role in Helios' strong growth and successful restructuring, leaving the business well positioned for the future. As we look ahead, I look forward to undertaking a search for a new Chief Executive Officer. Helios remains committed to its long term strategy of selecting the best-performing syndicates at Lloyd's to maximise returns for investors."

Michael Wade commented:

"Serving on the Board of Helios has provided a unique perspective across the whole Lloyd's Market. I leave Helios and its diverse portfolio of syndicates delivering strong results and well positioned and wish John and the Board all the best for the future."

Β 

Contact

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7260 1000

FTI Consulting

Ed Berry / Nathan Hambrook-Skinner +44 (0)7703 330 199 / +44 (0)7977 817 092

Β 

Β 

Β 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visitΒ www.huwplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAZZGGZRLRGKZM
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.